RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: substance-induced psychosis
Accession: DOID:8646
browse the term
Definition: Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Synonyms: exact_synonym: Drug Psychoses; Toxic Psychoses; substance-induced psychoses
primary_id: MESH:D011605 ; RDO:0006434
xref: ICD9CM:293.89
For additional species annotation, visit the
Alliance of Genome Resources .
G
ACE
angiotensin I converting enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADORA2A
adenosine A2a receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
AKT1
AKT serine/threonine kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr 7:44,217,154...44,326,167
Ensembl chr 7:44,217,150...44,334,577
G
ESR1
estrogen receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 6:151,654,148...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
GRM2
glutamate metabotropic receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 3:51,707,068...51,718,616
Ensembl chr 3:51,707,068...51,718,613
G
GSTP1
glutathione S-transferase pi 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656 Ensembl chr11:67,583,742...67,586,656
G
HTR1A
5-hydroxytryptamine receptor 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,960,356...63,962,507 Ensembl chr 5:63,960,356...63,962,507
G
HTR6
5-hydroxytryptamine receptor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 1:19,664,875...19,680,966
Ensembl chr 1:19,664,875...19,680,966
G
NPY1R
neuropeptide Y receptor Y1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 4:163,323,962...163,344,832
Ensembl chr 4:163,323,962...163,344,832
G
OPRM1
opioid receptor mu 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
PHB
prohibitin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr17:49,404,052...49,414,882
Ensembl chr17:49,404,049...49,414,905 Ensembl chr17:49,404,049...49,414,905
G
PICK1
protein interacting with PRKCA 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr22:38,056,311...38,075,704
Ensembl chr22:38,056,311...38,075,701
G
RGS9
regulator of G protein signaling 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr17:65,137,370...65,227,703
Ensembl chr17:65,100,812...65,227,703
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
SNCA
synuclein alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:89,724,099...89,838,324
Ensembl chr 4:89,700,345...89,838,315 Ensembl chr 4:89,700,345...89,838,315
G
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 Ensembl chr 6:159,669,069...159,762,529 Ensembl chr 6:159,669,069...159,762,529
G
ALDH2
aldehyde dehydrogenase 2 family member
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:71,095,851...71,103,534
Ensembl chr X:71,095,851...71,103,532
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
ANK3
ankyrin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
BPIFA1
BPI fold containing family A member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr20:33,235,996...33,243,306
Ensembl chr20:33,235,995...33,243,311
G
CAT
catalase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 , PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr12:13,537,337...13,982,012
Ensembl chr12:13,437,942...13,982,002 Ensembl chr12:13,437,942...13,982,002
G
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr12:102,395,860...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
NOS1
nitric oxide synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,863,625...87,971,930
G
RPS6KA1
ribosomal protein S6 kinase A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 1:26,529,761...26,575,028
Ensembl chr 1:26,529,761...26,575,030
G
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,145...49,412,998 Ensembl chr 3:49,359,145...49,412,998
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
IL1B
interleukin 1 beta
ISO
RGD
PMID:22959208
RGD:7204702
NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
treatment
IDA
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 2:113,099,365...113,134,016
Ensembl chr 2:113,107,214...113,134,016
G
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all